Publications by authors named "Niklas Axen"

Claim this Profile
L
Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.
Laurence Klotz, Stefan Grudén, Niklas Axén, Charlotta Gauffin, Cecilia Wassberg

Eur Urol Focus· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution of fluorescence-labelled EGF protein from slow release NanoZolid depots in mouse.
Stefan Grudén, Charlott Brunmark, Bo Holmqvist, Erwin D Brenndörfer, Martin Johansson

Int J Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.
Teuvo L Tammela, Michael Häggman, Sam Ladjevardi, Kimmo Taari, Taina Isotalo

J Urol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumoral effect and reduced systemic toxicity in mice after intra-tumoral injection of an in vivo solidifying calcium sulfate formulation with docetaxel.
Stefan Grudén, Martin Sandelin, Veera Rasanen, Patrick Micke, Mikael Hedeland

Eur J Pharm Biopharm· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of an injectable modified-release 2-hydroxyflutamide formulation in the human prostate gland using a semiphysiologically based biopharmaceutical model.
Erik Sjögren, Teuvo L Tammela, Bo Lennernäs, Kimmo Taari, Taina Isotalo

Mol Pharm· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systems.
Ilse R Dubbelboer, Elsa Lilienberg, Emelie Ahnfelt, Erik Sjögren, Niklas Axén

Ther Deliv· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of hepatobiliary disposition of doxorubicin following intrahepatic delivery of different dosage forms.
Elsa Lilienberg, Charlotte Ebeling Barbier, Rickard Nyman, Mikael Hedeland, Ulf Bondesson

Mol Pharm· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis